Compounds and compositions as smarca2/4 degraders and uses thereof
US-2026092071-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Li Zhenwu patents
Li Zhenwu is listed as an inventor on 45 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Li Zhenwu |
| Total patents | 45 |
| First publication | Oct 6, 2016 |
| Latest publication | Apr 2, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Bicyclic amines as cdk2 inhibitors
US-2026022119-A1 · Jan 22, 2026 · US
Bicyclic amines as CDK2 inhibitors
US-12466828-B2 · Nov 11, 2025 · US
Heterocyclic compounds as immunomodulators
US-12466822-B2 · Nov 11, 2025 · US
Cereblon ligands and uses thereof
US-2025195484-A1 · Jun 19, 2025 · US
Tricyclic compounds as inhibitors of kras
US-2025188073-A1 · Jun 12, 2025 · US
Bicyclic amines as cdk2 inhibitors
US-2024174664-A1 · May 30, 2024 · US
Bicyclic amines as CDK2 inhibitors
US-11851426-B2 · Dec 26, 2023 · US
Pd-l1/sting conjugates and methods of use
US-2023398225-A1 · Dec 14, 2023 · US
Tricyclic heterocyclic compounds as sting activators
US-11713317-B2 · Aug 1, 2023 · US
Recent patents
Latest publications not already listed above.
Heterocyclic compounds as immunomodulators
US-2023226062-A1 · Jul 20, 2023 · US
Heterocyclic compounds as immunomodulators
US-2023192689-A1 · Jun 22, 2023 · US
Tricyclic compounds as inhibitors of kras
US-2023114765-A1 · Apr 13, 2023 · US
Heterocyclic compounds as immunomodulators
US-11608337-B2 · Mar 21, 2023 · US
PD-L1/STING conjugates and methods of use
US-11596692-B1 · Mar 7, 2023 · US
Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
US-11472791-B2 · Oct 18, 2022 · US
Heterocyclic compounds as immunomodulators
US-11407749-B2 · Aug 9, 2022 · US
Heterocyclic compounds as LSD1 inhibitors
US-11401272-B2 · Aug 2, 2022 · US
Heterocyclic compounds as immunomodulators
US-2022213090-A1 · Jul 7, 2022 · US
Heterocyclic compounds as immunomodulators
US-2022194931-A1 · Jun 23, 2022 · US
Tricyclic heterocyclic compounds as sting activators
US-2022073509-A1 · Mar 10, 2022 · US
Heterocyclic compounds as immunomodulators
US-2021347771-A1 · Nov 11, 2021 · US
Tricyclic compounds as inhibitors of kras
US-2021269434-A1 · Sep 2, 2021 · US
Heterocyclic compounds as immunomodulators
US-2021107900-A1 · Apr 15, 2021 · US
Bicyclic amines as cdk2 inhibitors
US-2021107901-A1 · Apr 15, 2021 · US
Tricyclic heterocyclic compounds as sting activators
US-10947227-B2 · Mar 16, 2021 · US
Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
US-2021017156-A1 · Jan 21, 2021 · US
Heterocyclic compounds as immunomodulators
US-2021017175-A1 · Jan 21, 2021 · US
Heterocyclic compounds as lsd1 inhibitors
US-2020392143-A1 · Dec 17, 2020 · US
Heterocyclic compounds as LSD1 inhibitors
US-10800779-B2 · Oct 13, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Incyte Corp | 41 |
| Us Health | 2 |
| Univ Hawaii | 2 |
| Univ Michigan | 2 |
| Oncopia Therapeutics Inc D/B/A Sk Life Science Labs | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 38 |
| C07D471/04 | 37 |
| C07D487/04 | 34 |
| C07D519/00 | 20 |
| A61P31/12 | 16 |